[Federal Register Volume 66, Number 139 (Thursday, July 19, 2001)]
[Notices]
[Page 37658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-18007]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Compositions for Use To Deactivate 
Organophosphates

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent 5,695,750 entitled 
``Compositions for Use to Deactivate Organophosphates'' issued December 
9, 1997. This patent has been assigned to the United States Government 
as represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A method of detoxifying organophosphates 
using mutant cholinesterase which resists aging. The addition of oximes 
to the cholinesterase further retards aging of the cholinesterase.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-18007 Filed 7-18-01; 8:45 am]
BILLING CODE 3710-08-M